Clinical Trial Update: Study of Arformoterol Tartrate Inhalation Solution and Racemic Formoterol in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing arformoterol tartrate inhalation solution with racemic formoterol in adults with mild-to-moderate chronic obstructive pulmonary diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ARFORMOTEROL TARTRATE INHALATION SOLUTION (arformoterol tartrate inhalation solution)
• Racemic formoterol inhalation solution (formoterol)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: COPD | Phase 2 | Status: COMPLETED